Microbix Biosystems Inc. (MBX) - Total Liabilities
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has total liabilities worth CA$9.80 Million CAD (≈ $7.09 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See MBX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Microbix Biosystems Inc. - Total Liabilities Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Microbix Biosystems Inc. total assets.
Microbix Biosystems Inc. Competitors by Total Liabilities
The table below lists competitors of Microbix Biosystems Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HI SPAC 3
KQ:217500
|
Korea | ₩16.21 Billion |
|
Asuransi Harta Aman Pratama Tbk PT
JK:AHAP
|
Indonesia | Rp968.67 Billion |
|
China Crystal New Material
KQ:900250
|
Korea | ₩21.94 Billion |
|
Aurora Mobile Ltd
NASDAQ:JG
|
USA | $316.94 Million |
|
Etiler İnci Bufe Gida Sanayi ve Dis Ticaret AS
IS:ETILR
|
Turkey | TL802.86 Million |
|
Bumi Teknokultura Unggul Tbk
JK:BTEK
|
Indonesia | Rp3.43 Trillion |
|
E4U a.s.
PR:EFORU
|
Czech Republic | Kč26.34 Million |
|
Partnera Oyj
HE:PARTNE1
|
Finland | €26.74 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Microbix Biosystems Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Microbix Biosystems Inc. to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Microbix Biosystems Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual total liabilities of Microbix Biosystems Inc. from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | CA$9.62 Million ≈ $6.96 Million |
-1.81% |
| 2024-09-30 | CA$9.80 Million ≈ $7.09 Million |
-11.15% |
| 2023-09-30 | CA$11.03 Million ≈ $7.98 Million |
+34.39% |
| 2022-09-30 | CA$8.21 Million ≈ $5.94 Million |
-20.11% |
| 2021-09-30 | CA$10.27 Million ≈ $7.43 Million |
+14.42% |
| 2020-09-30 | CA$8.98 Million ≈ $6.49 Million |
-1.25% |
| 2019-09-30 | CA$9.09 Million ≈ $6.58 Million |
+1.51% |
| 2018-09-30 | CA$8.96 Million ≈ $6.48 Million |
-20.48% |
| 2017-09-30 | CA$11.26 Million ≈ $8.15 Million |
+13.13% |
| 2016-09-30 | CA$9.96 Million ≈ $7.20 Million |
+0.87% |
| 2015-09-30 | CA$9.87 Million ≈ $7.14 Million |
+21.00% |
| 2014-09-30 | CA$8.16 Million ≈ $5.90 Million |
+16.62% |
| 2013-09-30 | CA$6.99 Million ≈ $5.06 Million |
-25.47% |
| 2012-09-30 | CA$9.39 Million ≈ $6.79 Million |
+8.33% |
| 2011-09-30 | CA$8.66 Million ≈ $6.27 Million |
-0.01% |
| 2010-09-30 | CA$8.66 Million ≈ $6.27 Million |
+12.87% |
| 2009-09-30 | CA$7.68 Million ≈ $5.55 Million |
+9.93% |
| 2008-09-30 | CA$6.98 Million ≈ $5.05 Million |
+98.42% |
| 2007-09-30 | CA$3.52 Million ≈ $2.55 Million |
+41.96% |
| 2006-09-30 | CA$2.48 Million ≈ $1.79 Million |
+109.77% |
| 2005-09-30 | CA$1.18 Million ≈ $854.85K |
+8.30% |
| 2004-09-30 | CA$1.09 Million ≈ $789.31K |
+10.18% |
| 2003-09-30 | CA$990.31K ≈ $716.37K |
+64.25% |
| 2002-09-30 | CA$602.93K ≈ $436.15K |
-33.67% |
| 2001-09-30 | CA$908.94K ≈ $657.51K |
-20.48% |
| 2000-09-30 | CA$1.14 Million ≈ $826.84K |
+14.30% |
| 1999-09-30 | CA$1.00 Million ≈ $723.38K |
-50.00% |
| 1998-09-30 | CA$2.00 Million ≈ $1.45 Million |
+81.82% |
| 1997-09-30 | CA$1.10 Million ≈ $795.72K |
-- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more